MAOIs – does the evidence warrant their resurrection?

  title={MAOIs – does the evidence warrant their resurrection?},
  author={D. Menkes and P. Bosanac and D. Castle},
  journal={Australasian Psychiatry},
  pages={371 - 373}
  • D. Menkes, P. Bosanac, D. Castle
  • Published 2016
  • Medicine
  • Australasian Psychiatry
  • Objective: The place of monoamine oxidase inhibitors (MAOIs) in psychiatry is reviewed, and the question posed as to whether they are now justifiably disregarded by prescribers. Method: Multiple databases (PubMed, Medline, Embase, Cochrane) were interrogated to provide an overview regarding the use, efficacy and toxicity of MAOIs. Data regarding funded use of these agents in New Zealand were obtained from PHARMAC. Results: Evidence supports the use of MAOIs in major depressive disorder, certain… CONTINUE READING
    4 Citations


    The Role of Monoamine Oxidase Inhibitors in Current Psychiatric Practice
    • 95
    The serotonin syndrome.
    • H. Sternbach
    • Psychology, Medicine
    • The American journal of psychiatry
    • 1991
    • 889
    • PDF
    Antidepressants in bipolar disorder: the case for caution.
    • 321
    • PDF
    Advances in the treatment of depression
    • 49
    • PDF
    Antipsychotics in the treatment of delirium: a systematic review.
    • 148
    • PDF